Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tuberous Sclerosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT01690871
What this trial is testing

A Phase II Study of Orally Administered BEZ235 Monotherapy in Patients With Metastatic or Unresectable Malignant PEComa

Who this might be right for
Malignant PEComa (Perivascular Epithelioid Cell Tumors)
Novartis Pharmaceuticals
Not applicableLooking for participantsNCT07304856
What this trial is testing

Role of Extracellular Vesicles as Biomarkers of Pulmonary Involvement in Patients With Lymphangioleiomyomatosis and Tuberous Sclerosis Complex

Who this might be right for
Lymphangioleiomyomatosis (LAM)Extracellular Vesicles; Generation and Function
University of Milan 80
Testing effectiveness (Phase 2)Study completedNCT01289912
What this trial is testing

Trial of RAD001 and Neurocognition in Tuberous Sclerosis Complex (TSC)

Who this might be right for
Tuberous Sclerosis Complex
Mustafa Sahin 52
Large-scale testing (Phase 3)Ended earlyNCT04485104
What this trial is testing

Assessment of Adjunctive Cannabidiol Oral Solution (GWP42003-P) in Children With Tuberous Sclerosis Complex (TSC), Dravet Syndrome (DS), or Lennox-Gastaut Syndrome (LGS) Who Experience Inadequately-controlled Seizures

Who this might be right for
Seizure in Participants With Tuberous Sclerosis ComplexSeizure in Participants With Dravet SyndromeSeizure in Participants With Lennox-Gastaut Syndrome
Jazz Pharmaceuticals 3
Not applicableWithdrawnNCT04344626
What this trial is testing

Use of a Tonometer to Identify Epileptogenic Lesions During Pediatric Epilepsy Surgery

Who this might be right for
EpilepsyFocal Cortical DysplasiaTuberous Sclerosis+7 more
University of California, Los Angeles
Not applicableStudy completedNCT00001869
What this trial is testing

Official Record of Patients Diagnosed With Lymphangioleiomyomatosis (LAM)

Who this might be right for
Leiomyomatosis
National Heart, Lung, and Blood Institute (NHLBI) 400
Testing effectiveness (Phase 2)Study completedNCT06322342
What this trial is testing

Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent

Who this might be right for
Central Nervous System (CNS) LesionsBrain MetastasesBrain Neoplasms+22 more
Reveal Pharmaceuticals Inc. 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT05103358
What this trial is testing

Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1)

Who this might be right for
TumorTumor, SolidMetastasis+18 more
Aadi Bioscience, Inc. 120
Not applicableEnrolling By InvitationNCT06879665
What this trial is testing

TANDem-2: Closing the Gap to Interventions for TAND

Who this might be right for
Adult Caregivers of Individuals With TSCTuberous Sclerosis Complex (TSC)
Vrije Universiteit Brussel 30
Large-scale testing (Phase 3)Study completedNCT05218655
What this trial is testing

A Safety Study for Previously Treated Vatiquinone (PTC743) Participants With Inherited Mitochondrial Disease

Who this might be right for
Inherited Mitochondrial Disease
PTC Therapeutics 101
Large-scale testing (Phase 3)Study completedNCT01713946
What this trial is testing

A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures

Who this might be right for
Tuberous Sclerosis Complex-associated Refractory Seizures
Novartis Pharmaceuticals 366
Not applicableStudy completedNCT04198207
What this trial is testing

The Effectiveness and Safety of Vagus Nerve Stimulation for TRE

Who this might be right for
Tuberous Sclerosis ComplexEpilepsy
Beijing Children's Hospital 70
Not applicableStudy completedNCT04698538
What this trial is testing

TSC Remote Assessment and Intervention

Who this might be right for
TSC
University of California, Los Angeles 54
Not applicableStudy completedNCT00552955
What this trial is testing

Effect of Fasting on the Size of Abdominal Lymphatic Tumors in Women

Who this might be right for
LymphangioleiomyomasTuberous SclerosisLymphangioleiomyomatosis
National Heart, Lung, and Blood Institute (NHLBI) 35
Testing effectiveness (Phase 2)Study completedNCT05059327
What this trial is testing

Basimglurant (NOE-101) in Children, Adolescents, and Young Adults With TSC

Who this might be right for
Tuberous Sclerosis Complex
Noema Pharma AG 61
Large-scale testing (Phase 3)Looking for participantsNCT07403266
What this trial is testing

Treatment With Full-spectrum Cannabis Extract of Refractory Epilepsy Associated With Tuberous Sclerosis Complex (TSC)

Who this might be right for
Tuberous Sclerosis Complex (TSC)
Oils4Cure 84
Large-scale testing (Phase 3)Study completedNCT05495425
What this trial is testing

Clinical Study of NPC-12Y Gel in Patients With Skin Lesions Associated With TSC

Who this might be right for
Tuberous Sclerosis Complex
Nobelpharma 43
Testing effectiveness (Phase 2)Study completedNCT04595513
What this trial is testing

Stopping TSC Onset and Progression 2: Epilepsy Prevention in TSC Infants

Who this might be right for
Tuberous Sclerosis ComplexEpilepsy
Children's Hospital Medical Center, Cincinnati 5
Not applicableLooking for participantsNCT05676099
What this trial is testing

TSC Biosample Repository and Natural History Database

Who this might be right for
Tuberous SclerosisLymphangioleiomyomatosis
National Tuberous Sclerosis Association 5,000
Testing effectiveness (Phase 2)Study completedNCT05364021
What this trial is testing

Study to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies

Who this might be right for
Developmental and Epileptic EncephalopathyDravet SyndromeLennox Gastaut Syndrome
Longboard Pharmaceuticals 52
Next Page